妊娠期高血压的解痉治疗

Antispasmodic treatment of gestational hypertension

妊娠期高血压是备受全球产科医生关注的影响全身多系统的疾病,是孕产妇和围产儿死亡的主要原因之一,并对母婴有着长远影响。解痉是现有两大主要临床治疗方案之一,硫酸镁是解痉的首选药物,但目前对其治疗时机、用量等仍有争议。本文主要综述硫酸镁在妊娠期高血压临床治疗中的应用时机、治疗方案及其对围产儿的影响,以及其他解痉药物等的应用评价,以期为临床治疗提供参考。

Gestational hypertension is a systemic disease concerned by obstetricians, which may cause the death of maternal and fetal. Usually, the prevention of eclampsia and its treatment are widely used as a major approach, and the magnesium sulfate(MgSO_4) is the drug of first choice. However, the debate about the MgSO_4 treatment condition and its durations still exists. This review summarizes the application scheme of Mg SO_4 treatment, and its influence to perinatal infants, and other related antispasmodic drugs, to provide a reference for clinical treatment.